Cargando…
Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer
Prostate cancer management is complicated by extreme disease heterogeneity, which is further limited by availability of prognostic biomarkers. Recognition of prostate cancer as a genetic disease has prompted a focus on the nuclear genome for biomarker discovery, with little attention given to the mi...
Autores principales: | Kalsbeek, Anton M.F., Chan, Eva F.K., Grogan, Judith, Petersen, Desiree C., Jaratlerdsiri, Weerachai, Gupta, Ruta, Lyons, Ruth J., Haynes, Anne Maree, Horvath, Lisa G., Kench, James G., Stricker, Phillip D., Hayes, Vanessa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191864/ https://www.ncbi.nlm.nih.gov/pubmed/27705925 http://dx.doi.org/10.18632/aging.101044 |
Ejemplares similares
-
The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective Analysis
por: Crumbaker, Megan, et al.
Publicado: (2020) -
Metagenomic analysis reveals a rich bacterial content in high‐risk prostate tumors from African men
por: Feng, Ye, et al.
Publicado: (2019) -
African-specific molecular taxonomy of prostate cancer
por: Jaratlerdsiri, Weerachai, et al.
Publicado: (2022) -
Prostate cancer genomics and racial health disparity
por: Hayes, Vanessa M., et al.
Publicado: (2018) -
p53 nuclear accumulation as an early indicator of lethal prostate cancer
por: Quinn, David I., et al.
Publicado: (2019)